You just read:

BioVentrix Announces Successful First-In-Man, Catheter-Based Endovascular Clinical Procedure with Revivent-TC™ System for Heart Failure Treatment

News provided by

BioVentrix, Inc.

May 16, 2016, 00:00 ET